Skip navigation and go to main content
Get Started

Your partner throughout the pipeline

Where Molecules Become Medicine

A next-generation CDMO for oral solid dosage forms, delivering end-to-end services from clinic to commercial

27 GMP suites and 5 dedicated non-GMP suites operated by highly experienced teams with deep institutional knowledge

  • Early-Phase Clinical Material

    From preclinical to Phase II, we offer rapid, small-scale formulation development designed for agility and accessibility.

    Explore Clinical Development

  • Late-Phase & Commercial Product

    Build upon a legacy of commercial excellence with a 100,000 sq. ft. facility capable of delivering over two billion doses annually.

    Explore Commercial Production

Manufacturing Capabilities

Forma specializes in the manufacture of complex oral solid dosage forms, including potent compounds and controlled substances.

  • Rapid to Clinic
  • Formulation Precision
  • Scale to Commercial

  • Dosage forms

    Comprehensive oral solid dosage capabilities, including tablets, capsules, and complex modified release formulations.

  • Controlled Substances

    Licensed handling and manufacturing of Schedule II–V compounds with specialized infrastructure for secure and compliant production.

  • Potency Capability

    Specialized containment for high-potency APIs, supporting compounds up to OHC 3 with controlled exposure limits

Irvine, California

Our California-based facilities provide the specialized infrastructure to scale your most complex products.

Over 100,000 sq. ft. across two specialized California facilities, including 27 GMP suites, 5 non-GMP suites, and 5,000 sq. ft. of analytical laboratory space. Both sites have a longstanding history of FDA-registered commercial manufacturing operations.

  • 27 GMP Suites
  • 5 non-GMP Suites

Latest Research & Updates

Insights from a next-generation CDMO led by builders, providing direct access to the experts who scale your science.